Regulation of CD8+ T cell responses to infection with parasitic protozoa

Experimental Parasitology

Volumn 126, Issue 3, 2010, Pages 318-325

  Jordan, Kimberly A ^a   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CD8+ T cell responses; Cellular immunity; Plasmodium; Protozoa; T cell memory; Toxoplasma gondii; Trypanosoma cruzi; Vaccines

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 27; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MALARIA VACCINE; PERFORIN; TOXOPLASMA GONDII VACCINE; TUMOR NECROSIS FACTOR ALPHA; PROTOZOAL VACCINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION RESISTANCE; LEISHMANIA; MALARIA; MEMORY T LYMPHOCYTE; NONHUMAN; PARASITE TRANSMISSION; PARASITOSIS; PHENOTYPIC PLASTICITY; PLASMODIUM; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRYPANOSOMA CRUZI; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PROTOZOAL INFECTION; TOXOPLASMA;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOLOGIC MEMORY; LEISHMANIA; PLASMODIUM; PROTOZOAN INFECTIONS; PROTOZOAN VACCINES; TOXOPLASMA; TRYPANOSOMA CRUZI;

LEISHMANIA SP.; MUS MUSCULUS; PLASMODIUM SP.; PROTOZOA; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI;

EID: 77956252678     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.05.008     Document Type: Article

References (168)

1. Afonso L.C., Scharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994, 263:235-237.
2. Anderson C.F., Mendez S., Sacks D.L. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. Journal of Immunology 2005, 174:2934-2941.
3. Anderson T. Mapping the spread of malaria drug resistance. PLoS Medicine 2009, 6:e1000054.
4. Andreakos E., Williams R.O., Wales J., Foxwell B.M., Feldmann M. Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:14459-14464.
5. Antonelli L.R., Dutra W.O., Almeida R.P., Bacellar O., Gollob K.J. Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation. Clinical and Experimental Immunology 2004, 136:341-348.
6. Araya J.E., Cano M.I., Yoshida N., da Silveira J.F. Cloning and characterization of a gene for the stage-specific 82-kDa surface antigen of metacyclic trypomastigotes of Trypanosoma cruzi. Molecular and Biochemical Parasitology 1994, 65:161-169.
7. Artis D., Johnson L.M., Joyce K., Saris C., Villarino A., Hunter C.A., Scott P. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. Journal of Immunology 2004, 172:4672-4675.
8. Aspinall T.V., Joynson D.H., Guy E., Hyde J.E., Sims P.F. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. Journal of Infectious Diseases 2002, 185:1637-1643.
9. + T cell generation after acute infection. Journal of Immunology 2007, 179:53-63.
10. Barber D.L., Wherry E.J., Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. Journal of Immunology 2003, 171:27-31.
11. Barral-Netto M., Barral A., Brodskyn C., Carvalho E.M., Reed S.G. Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunology 1995, 17:21-28.
12. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. Journal of Immunology 2002, 168:3992-4000.
13. + T cells by Leishmania major-infected dendritic cells. Infection and Immunity 2005, 73:6620-6628.
14. + T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. Journal of Immunology 2006, 177:3525-3533.
15. + T cell memory during persistent Trypanosoma cruzi infection. Journal of Immunology 2008, 181:2644-2650.
16. Blanchard N., Gonzalez F., Schaeffer M., Joncker N.T., Cheng T., Shastri A.J., Robey E.A., Shastri N. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nature Immunology 2008, 9:937-944.
17. + T cells in vitro. Journal of Immunology 2007, 178:7054-7063.
18. Braga E.M., Carvalho L.H., Fontes C.J., Krettli A.U. Low cellular response in vitro among subjects with long-term exposure to malaria transmission in Brazilian endemic areas. American Journal of Tropical Medicine and Hygiene 2002, 66:299-303.
19. Brodskyn C.I., Barral A., Bulhoes M.A., Souto T., Machado W.C., Barral-Netto M. Cytotoxicity in patients with different clinical forms of Chagas' disease. Clinical and Experimental Immunology 1996, 105:450-455.
20. + T cells determine cyst number in Toxoplasma gondii infection. Journal of Immunology 1990, 145:3438-3441.
21. + T central memory response in chronic Chagas disease. Nature Medicine 2008, 14:542-550.
22. Buxton D., Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology 1995, 110(Suppl.):S11-S16.
23. + T-cell responses against malaria liver stages. Nature Medicine 2002, 8:166-170.
24. Casciotti L., Ely K.H., Williams M.E., Khan I.A. CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells. Infection and Immunity 2002, 70:434-443.
25. + T cells. Journal of Immunology 2009, 182:3380-3389.
26. Cox-Singh J., Davis T.M., Lee K.S., Shamsul S.S., Matusop A., Ratnam S., Rahman H.A., Conway D.J., Singh B. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clinical Infectious Diseases 2008, 46:165-171.
27. Cox-Singh J., Singh B. Knowlesi malaria: newly emergent and of public health importance?. Trends in Parasitolology 2008, 24:406-410.
28. + T cells associated with cure of human cutaneous leishmaniasis. Infection and Immunity 1994, 62:2614-2618.
29. Demar M., Ajzenberg D., Maubon D., Djossou F., Panchoe D., Punwasi W., Valery N., Peneau C., Daigre J.L., Aznar C., et al. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clinical Infectious Diseases 2007, 45:e88-e95.
30. Denkers E.Y., Gazzinelli R.T., Hieny S., Caspar P., Sher A. Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. Journal of Immunology 1993, 150:517-526.
31. Denkers E.Y., Gazzinelli R.T., Martin D., Sher A. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. The Journal of Experimental Medicine 1993, 178:1465-1472.
32. Denkers E.Y., Yap G., Scharton-Kersten T., Charest H., Butcher B.A., Caspar P., Heiny S., Sher A. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. Journal of Immunology 1997, 159:1903-1908.
33. + T cells in the Plasmodium yoelii model. Journal of Immunology 1999, 163:884-892.
34. Doolan D.L., Hoffman S.L. The complexity of protective immunity against liver-stage malaria. Journal of Immunology 2000, 165:1453-1462.
35. Doolan D.L., Hoffman S.L., Southwood S., Wentworth P.A., Sidney J., Chesnut R.W., Keogh E., Appella E., Nutman T.B., Lal A.A., et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 1997, 7:97-112.
36. Doolan D.L., Khamboonruang C., Beck H.P., Houghten R.A., Good M.F. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. International Immunology 1993, 5:37-46.
37. Dzierszinski F., Pepper M., Stumhofer J.S., LaRosa D.F., Wilson E.H., Turka L.A., Halonen S.K., Hunter C.A., Roos D.S. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infection and Immunity 2007, 75:5200-5209.
38. El-Sayed N.M., Myler P.J., Bartholomeu D.C., Nilsson D., Aggarwal G., Tran A.N., Ghedin E., Worthey E.A., Delcher A.L., Blandin G., et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005, 309:409-415.
39. + T cells do not mediate a protective immune response. Immunobiology 1996, 195:243-260.
40. Ferreira M.S., Borges A.S. Some aspects of protozoan infections in immunocompromised patients - a review. Memorias do Instituto Oswaldo Cruz 2002, 97:443-457.
41. + epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes and Infection 2005, 7:688-697.
42. Fralish B.H., Tarleton R.L. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine 2003, 21:3070-3080.
43. Frenkel J.K. Pathophysiology of toxoplasmosis. Parasitology Today 1988, 4:273-278.
44. + T cell epitopes. Journal of Infectious Diseases 2008, 198:1625-1633.
45. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
46. Garg N., Nunes M.P., Tarleton R.L. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. Journal of Immunology 1997, 158:3293-3302.
47. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. Journal of Immunology 1992, 149:175-180.
48. + T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Journal of Immunology 1991, 146:286-292.
49. Gazzinelli R.T., Hartley J.W., Fredrickson T.N., Chattopadhyay S.K., Sher A., Morse H.C. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infection and Immunity 1992, 60:4394-4401.
50. + T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Journal of Immunology 1996, 157:798-805.
51. Goldszmid R.S., Coppens I., Lev A., Caspar P., Mellman I., Sher A. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. Journal of Experimental Medicine 2009, 206:399-410.
52. Good M.F. Vaccine-induced immunity to malaria parasites and the need for novel strategies. Trends in Parasitolology 2005, 21:29-34.
53. Grigg M.E., Ganatra J., Boothroyd J.C., Margolis T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. Journal of Infectious Diseases 2001, 184:633-639.
54. Gubbels M.J., Striepen B., Shastri N., Turkoz M., Robey E.A. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infection and Immunity 2005, 73:703-711.
55. + T cells during the course of blood-stage malarial infection. Journal of Infectious Diseases 2007, 196:1827-1835.
56. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. Journal of Immunology 1991, 147:2310-2316.
57. Hamano S., Himeno K., Miyazaki Y., Ishii K., Yamanaka A., Takeda A., Zhang M., Hisaeda H., Mak T.W., Yoshimura A., Yoshida H. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 2003, 19:657-667.
58. Herrera-Najera C., Pina-Aguilar R., Xacur-Garcia F., Ramirez-Sierra M.J., Dumonteil E. Mining the Leishmania genome for novel antigens and vaccine candidates. Proteomics 2009, 9:1293-1301.
59. Huber M., Timms E., Mak T.W., Rollinghoff M., Lohoff M. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infection and Immunity 1998, 66:3968-3970.
60. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D., Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. Journal of Immunology 1997, 158:3311-3316.
61. + T cells lacking T-bet and eomesodermin. Science 2008, 321:408-411.
62. + T cell fate coupled by T-bet and eomesodermin. Nature Immunology 2005, 6:1236-1244.
63. Ivens A.C., Peacock C.S., Worthey E.A., Murphy L., Aggarwal G., Berriman M., Sisk E., Rajandream M.A., Adlem E., Aert R., et al. The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309:436-442.
64. John B., Harris T.H., Tait E.D., Wilson E.H., Gregg B., Ng L.G., Mrass P., Roos D.S., Dzierszinski F., Weninger W., Hunter C.A. Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathogens 2009, 5:e1000505.
65. Johnson L.L. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection. Infection and Immunity 1992, 60:1979-1983.
66. + T-cell responses to Toxoplasma gondii. Infection and Immunity 2009, 77:3894-3901.
67. Joshi N.S., Cui W., Chandele A., Lee H.K., Urso D.R., Hagman J., Gapin L., Kaech S.M. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007, 27:281-295.
68. Jung S., Unutmaz D., Wong P., Sano G., De los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002, 17:211-220.
69. Kane M.M., Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. Journal of Immunology 2001, 166:1141-1147.
70. Katae M., Miyahira Y., Takeda K., Matsuda H., Yagita H., Okumura K., Takeuchi T., Kamiyama T., Ohwada A., Fukuchi Y., Aoki T. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy. Infection and Immunity 2002, 70:4833-4840.
71. Kelly M.N., Kolls J.K., Happel K., Schwartzman J.D., Schwarzenberger P., Combe C., Moretto M., Khan I.A. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infection and Immunity 2005, 73:617-621.
72. Khan A., Jordan C., Muccioli C., Vallochi A.L., Rizzo L.V., Belfort R., Vitor R.W., Silveira C., Sibley L.D. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerging Infectious Diseases 2006, 12:942-949.
73. + T cell immunity against fatal Toxoplasma gondii infection in mice. Journal of Immunology 1991, 147:3501-3506.
74. Khan I.A., Smith K.A., Kasper L.H. Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii. Journal of Clinical Investigation 1990, 85:1879-1886.
75. Khatoon L., Baliraine F.N., Bonizzoni M., Malik S.A., Yan G. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. American Journal of Tropical Medicine and Hygiene 2009, 81:525-528.
76. + cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infection and Immunity 1994, 62:2979-2983.
77. Kim S.K., Boothroyd J.C. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. Journal of Immunology 2005, 174:8038-8048.
78. Kissinger J.C., Gajria B., Li L., Paulsen I.T., Roos D.S. ToxoDB: accessing the Toxoplasma gondii genome. Nucleic Acids Research 2003, 31:234-236.
79. Kumar K.A., Sano G., Boscardin S., Nussenzweig R.S., Nussenzweig M.C., Zavala F., Nussenzweig V. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006, 444:937-940.
80. Kumar S., Tarleton R.L. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. Journal of Immunology 2001, 166:4596-4603.
81. Kwok L.Y., Lutjen S., Soltek S., Soldati D., Busch D., Deckert M., Schluter D. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. Journal of Immunology 2003, 170:1949-1957.
82. Laucella S.A., Postan M., Martin D., Hubby Fralish B., Albareda M.C., Alvarez M.G., Lococo B., Barbieri G., Viotti R.J., Tarleton R.L. Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. Journal of Infectious Diseases 2004, 189:909-918.
83. Launois P., Conceicao-Silva F., Himmerlich H., Parra-Lopez C., Tacchini-Cottier F., Louis J.A. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major. Parasite Immunology 1998, 20:223-230.
84. Li C., Corraliza I., Langhorne J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infection and Immunity 1999, 67:4435-4442.
85. Lieberman L.A., Banica M., Reiner S.L., Hunter C.A. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. Journal of Immunology 2004, 172:457-463.
86. + T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. Journal of Experimental Medicine 1996, 184:597-607.
87. Liu C.H., Fan Y.T., Dias A., Esper L., Corn R.A., Bafica A., Machado F.S., Aliberti J. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. Journal of Immunology 2006, 177:31-35.
88. Luft B.J., Brooks R.G., Conley F.K., McCabe R.E., Remington J.S. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 1984, 252:913-917.
89. + dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:14509-14514.
90. Lutjen S., Soltek S., Virna S., Deckert M., Schluter D. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells. Infection and Immunity 2006, 74:5790-5801.
91. + T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathogens 2006, 2:e77.
92. Mason N.J., Liou H.C., Hunter C.A. T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii. Journal of Immunology 2004, 172:3704-3711.
93. + T cells during blood stage of Plasmodium berghei infection. Journal of Immunology 2008, 181:1420-1428.
94. Mogil R.J., Patton C.L., Green D.R. Cellular subsets involved in cell-mediated immunity to murine Plasmodium yoelii 17X malaria. Journal of Immunology 1987, 138:1933-1939.
95. Moll H., Scollay R., Mitchell G.F. Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells. Immunology and Cell Biology 1988, 66(Pt 1):57-63.
96. + T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Infection and Immunity 1996, 64:176-181.
97. Mueller A.K., Deckert M., Heiss K., Goetz K., Matuschewski K., Schluter D. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. American Journal of Pathology 2007, 171:107-115.
98. + T cells. Infection and Immunity 1993, 61:3730-3738.
99. + T cells following secondary infection of mice immune to Leishmania major. Infection and Immunity 1994, 62:2575-2581.
100. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Wetzel K., Maier C., Birkett A.J., Sarpotdar P., Corado M.L., Thornton G.B., Schmidt A. Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes. Infection and Immunity 2004, 72:6519-6527.
101. + T lymphocytes mediate experimental cerebral malaria pathogenesis. Journal of Immunology 2003, 170:2221-2228.
102. Nobrega A.A., Garcia M.H., Tatto E., Obara M.T., Costa E., Sobel J., Araujo W.N. Oral transmission of Chagas disease by consumption of acai palm fruit, Brazil. Emerging Infectious Diseases 2009, 15:653-655.
103. Nussenzweig R.S., Vanderberg J., Most H., Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 1967, 216:160-162.
104. Oliveira G.A., Wetzel K., Calvo-Calle J.M., Nussenzweig R., Schmidt A., Birkett A., Dubovsky F., Tierney E., Gleiter C.H., Boehmer G., et al. Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Infection and Immunity 2005, 73:3587-3597.
105. Overath P., Harbecke D. Course of Leishmania infection in beta 2-microglobulin-deficient mice. Immunology Letters 1993, 37:13-17.
106. + T cells. Infection and Immunity 2007, 75:231-235.
107. + T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clinical and Experimental Immunology 1991, 84:207-212.
108. Pearce E.L., Shen H. Generation of CD8 T cell memory is regulated by IL-12. Journal of Immunology 2007, 179:2074-2081.
109. Pearce R.J., Pota H., Evehe M.S., Bael H., Mombo-Ngoma G., Malisa A.L., Ord R., Inojosa W., Matondo A., Diallo D.A., et al. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Medicine 2009, 6:e1000055.
110. +-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infection and Immunity 2004, 72:7240-7246.
111. Plebanski M., Aidoo M., Whittle H.C., Hill A.V. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. Journal of Immunology 1997, 158:2849-2855.
112. Plebanski M., Hannan C.M., Behboudi S., Flanagan K.L., Apostolopoulos V., Sinden R.E., Hill A.V. Direct processing and presentation of antigen from malaria sporozoites by professional antigen-presenting cells in the induction of CD8 T-cell responses. Immunology and Cell Biology 2005, 83:307-312.
113. + T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infection and Immunity 1991, 59:51-58.
114. Potter S., Chan-Ling T., Ball H.J., Mansour H., Mitchell A., Maluish L., Hunt N.H. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. International Journal for Parasitology 2006, 36:485-496.
115. Purner M.B., Berens R.L., Nash P.B., van Linden A., Ross E., Kruse C., Krug E.C., Curiel T.J. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infection and Immunity 1996, 64:4330-4338.
116. Rafati S., Kariminia A., Seyde-Eslami S., Narimani M., Taheri T., Lebbatard M. Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation. Vaccine 2002, 20:2439-2447.
117. + T cells following infection with herpes simplex virus type 1. Journal of Virology 2009, 83:5256-5268.
118. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annual Review of Immunology 1995, 13:151-177.
119. Robello C., Navarro P., Castanys S., Gamarro F. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi. Molecular and Biochemical Parasitology 1997, 90:525-535.
120. Rock K.L., Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunological Reviews 2005, 207:166-183.
121. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. International Immunology 1991, 3:579-585.
122. Roggero E., Perez A., Tamae-Kakazu M., Piazzon I., Nepomnaschy I., Wietzerbin J., Serra E., Revelli S., Bottasso O. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clinical and Experimental Immunology 2002, 128:421-428.
123. Romero J.F., Ibrahim G.H., Renggli J., Himmelrich H., Graber P., Corradin G. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations. Parasite Immunology 2007, 29:541-548.
124. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341:323-326.
125. Scharton-Kersten T.M., Wynn T.A., Denkers E.Y., Bala S., Grunvald E., Hieny S., Gazzinelli R.T., Sher A. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. Journal of Immunology 1996, 157:4045-4054.
126. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330:664-666.
127. Schonfeld M., Barreto Miranda I., Schunk M., Maduhu I., Maboko L., Hoelscher M., Berens-Riha N., Kitua A., Loscher T. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania. Malaria Journal 2007, 6:2.
128. Schunk M., Kumma W.P., Miranda I.B., Osman M.E., Roewer S., Alano A., Loscher T., Bienzle U., Mockenhaupt F.P. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Malaria Journal 2006, 5:54.
129. + cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Journal of Immunology 1992, 149:966-971.
130. + T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice. Microbiology and Immunology 1994, 38:789-796.
131. Steindel M., Kramer Pacheco L., Scholl D., Soares M., de Moraes M.H., Eger I., Kosmann C., Sincero T.C., Stoco P.H., Murta S.M., et al. Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. Diagnostic Microbiology and Infectious Disease 2008, 60:25-32.
132. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunology 2006, 7:937-945.
133. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. Journal of Immunology 1991, 147:3955-3959.
134. Suphavilai C., Looareesuwan S., Good M.F. Analysis of circumsporozoite protein-specific immune responses following recent infection with Plasmodium vivax. American Journal of Tropical Medicine and Hygiene 2004, 71:29-39.
135. Surh C.D., Boyman O., Purton J.F., Sprent J. Homeostasis of memory T cells. Immunological Reviews 2006, 211:154-163.
136. Suzuki Y., Conley F.K., Remington J.S. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. Journal of Immunology 1989, 143:2045-2050.
137. Suzuki Y., Joh K., Kwon O.C., Yang Q., Conley F.K., Remington J.S. MHC class I gene(s) in the D/L region but not the TNF-alpha gene determines development of toxoplasmic encephalitis in mice. Journal of Immunology 1994, 153:4649-4654.
138. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988, 240:516-518.
139. + T cells in mice. Journal of Immunology 1988, 140:3943-3946.
140. Suzuki Y., Wong S.Y., Grumet F.C., Fessel J., Montoya J.G., Zolopa A.R., Portmore A., Schumacher-Perdreau F., Schrappe M., Koppen S., et al. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. Journal of Infectious Diseases 1996, 173:265-268.
141. + T cell differentiation. Journal of Immunology 2006, 177:7515-7519.
142. + T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. Journal of Immunology 1990, 144:717-724.
143. Tarleton R.L., Koller B.H., Latour A., Postan M. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992, 356:338-340.
144. Tarleton R.L., Sun J., Zhang L., Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infection and Immunity 1994, 62:1820-1829.
145. Torrico F., Heremans H., Rivera M.T., Van Marck E., Billiau A., Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology 1991, 146:3626-3632.
146. Tsuji M., Zavala F. T cells as mediators of protective immunity against liver stages of Plasmodium. Trends in Parasitology 2003, 19:88-93.
147. Ubeda J.M., Legare D., Raymond F., Ouameur A.A., Boisvert S., Rigault P., Corbeil J., Tremblay M.J., Olivier M., Papadopoulou B., Ouellette M. Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biology 2008, 9:R115.
148. + T cells. Journal of Experimental Medicine 2004, 199:1559-1566.
149. Valente S.A., da Costa Valente V., das Neves Pinto A.Y., de Jesus Barbosa Cesar M., dos Santos M.P., Miranda C.O., Cuervo P., Fernandes O. Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009, 291-297.
150. Valmori D., Romero J.F., Men Y., Maryanski J.L., Romero P., Corradin G. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. European Journal of Immunology 1994, 24:1458-1462.
151. + cell-deficient beta 2-m0/0 mice. Journal of Immunology 1993, 151:3187-3191.
152. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., Kastelein R.A., Saris C., Hunter C.A. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003, 19:645-655.
153. + T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria. Journal of Immunology 1990, 144:1069-1074.
154. + T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. Journal of Immunology 2004, 172:5561-5569.
155. Wang Z.E., Reiner S.L., Hatam F., Heinzel F.P., Bouvier J., Turck C.W., Locksley R.M. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. Journal of Immunology 1993, 151:2077-2086.
156. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:573-576.
157. Widmann C., Romero P., Maryanski J.L., Corradin G., Valmori D. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. Journal of Immunological Methods 1992, 155:95-99.
158. Wilkinson S.R., Taylor M.C., Horn D., Kelly J.M., Cheeseman I. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:5022-5027.
159. + T cells. PLoS Pathogens 2010, 6:e1000815.
160. + effector subpopulations during Toxoplasma gondii Infection. Journal of Immunology 2008, 180:5935-5945.
161. + T cell responses. Journal of Immunology 2008, 181:7445-7448.
162. Wilson E.H., Wille-Reece U., Dzierszinski F., Hunter C.A. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. Journal of Neuroimmunology 2005, 165:63-74.
163. + TC1 responses. Journal of Immunology 1997, 159:6120-6130.
164. Wizel B., Palmieri M., Mendoza C., Arana B., Sidney J., Sette A., Tarleton R. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. Journal of Clinical Investigation 1998, 102:1062-1071.
165. + cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells. Parasite Immunology 2002, 24:401-412.
166. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., Xia M., Wakeham A.C., Nishina H., Potter J., et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001, 15:569-578.
167. Zhang L., Tarleton R.L. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. European Journal of Immunology 1996, 26:102-109.
168. Zhang L., Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. Journal of Infectious Diseases 1999, 180:480-486.